{
    "id": "correct_foundationPlace_00119_0",
    "rank": 47,
    "data": {
        "url": "https://www.ypsomed.com/pl-PL/wiadomosci/tag/innovation.html",
        "read_more_link": "",
        "language": "en",
        "title": "Publikacje w prasie",
        "top_image": "https://www.ypsomed.com/files/ypsomed2019/images/favicons/favicon-32x32.png",
        "meta_img": "https://www.ypsomed.com/files/ypsomed2019/images/favicons/favicon-32x32.png",
        "images": [
            "https://www.ypsomed.com/pl-PL/wiadomosci/tag/files/ypsomed2019/images/logo_claim_ypsomed.svg",
            "https://www.ypsomed.com/pl-PL/wiadomosci/tag/files/media/01_Layout/01_Banner_Images/YPS_PRD_BUCH_Media_Investors_0398.jpg",
            "https://www.ypsomed.com/pl-PL/wiadomosci/tag/assets/images/5/Social_FB_LinkedIn-MY_PWP_WomanPregnant_1432505073-88601b60.jpg",
            "https://www.ypsomed.com/pl-PL/wiadomosci/tag/assets/images/a/Partnerschaft%20S3%20Connected%20Health%20und%20Ypsomed_web-221a033c.jpg",
            "https://www.ypsomed.com/pl-PL/wiadomosci/tag/assets/images/8/Companion-remote-monitoring_ohne_Rand_FB-02d2c988.jpg",
            "https://www.ypsomed.com/pl-PL/wiadomosci/tag/assets/images/2/YPS_Innovations_Fund_machineMD_low-c1a1b774.jpg",
            "https://www.ypsomed.com/pl-PL/wiadomosci/tag/assets/images/0/Loop_Libre_camAPS_V3_YpsoPump_Media_de-DE-6031cb5b.jpg",
            "https://www.ypsomed.com/pl-PL/wiadomosci/tag/files/ypsomed2019/images/base/content/logo_ypsomed_small_white.svg"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": "2023-10-12T07:00:00+02:00",
        "summary": "",
        "meta_description": "Read the latest news from Ypsomed.",
        "meta_lang": "pl",
        "meta_favicon": "/files/ypsomed2019/images/favicons/apple-touch-icon.png",
        "meta_site_name": "",
        "canonical_link": "https://www.ypsomed.com/pl-PL/wiadomosci/tag/innovation.html",
        "text": "Burgdorf – Pregnant women with type 1 diabetes and their babies benefit from treatment with a hybrid closed loop system based on the CamAPS FX algorithm. This is demonstrated by the AiDAPT clinical study, which clinical outcomes were published in the New England Journal of Medicine and the experience of the pregnant women in Diabetes Technology and Therapeutics, both on 5 October 2023. The algorithm of Ypsomed's mylife Loop, the CamAPS FX app is the only automated insulin delivery (AID) algorithm approved for pregnant women with type 1 diabetes.\n\nWięcej... mylife Loop improves health of pregnant women with type 1 diabetes and their babies\n\nBurgdorf – Ypsomed (SIX: YPSN) will expand its offering of digital health solutions together with S3 Connected Health in the future. S3 Connected Health, headquartered in Dublin, Ireland is a specialist digital health partner for life science companies. The new offering will allow Ypsomed’s biopharma customers to quickly launch therapy-specific digital patient solutions. People with acute and chronic diseases can thus be supported fully in their therapy management and the outcome of their treatment can be enhanced.\n\nWięcej... Ypsomed partners with S3 Connected Health to expand its digital health offering\n\nBurgdorf – Parents and caregivers of children with diabetes can now follow their child's glucose and insulin data via the mylife CamAPS FX app on their own personal smartphone. The new \"Companion remote monitoring\" feature is fully integrated into the app. It gives parents and caregivers better control and peace of mind.\n\nWięcej... mylife Loop offers new remote monitoring feature for parents\n\nBurgdorf - The winners of the Ypsomed Innovation Award 2022 were honoured yesterday evening at the PwC Switzerland New Year's Apéro in Bern. The winners are machineMD (1st place), Pace Locator (2nd place) and Compact Motion (3rd place). The Innovation Award, worth a total of CHF 100,000, is presented every two years by the Ypsomed Innovation Fund Foundation. The aim is to promote the transfer of knowledge and technology from universities of applied sciences and universities in the \"Espace Mittelland\" region.\n\nWięcej... Winners of the Ypsomed Innovation Award 2022 announced\n\nBurgdorf – Ypsomed announces that its mylife Loop is now authorized to work with Abbott’s FreeStyle Libre 3 sensor in Germany. The mylife YpsoPump and the FreeStyle Libre 3, combined with the mylife CamAPS FX algorithm from CamDiab, form an intelligent and automated insulin delivery system (AID) designed to help people with type 1 diabetes to better control their glucose levels and alleviate the burden of daily diabetes management.\n\nWięcej... Ypsomed and CamDiab launch the first system for automated insulin dosing with Abbott’s FreeStyle Libre 3"
    }
}